MktsMarkets

Atossa Therapeutics, Inc.
NASDAQ: ATOSKey statistics
ATOS News
Stories mentioning ATOS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 4,779 | 6,156 | 5,370 | 5,502 | 4,157 | 3,404 | 3,412 | 3,553 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 9,870 | 11,436 | 9,251 | 9,040 | 7,414 | 7,151 | 6,385 | 7,105 |
| Operating Income (Loss) | (9,870) | (11,436) | (9,251) | (9,040) | (7,414) | (7,151) | (6,385) | (7,105) |
| Interest Income | 309.00 | 442.00 | 570.00 | 645.00 | 720.00 | 838.00 | 1,001 | 1,073 |
| Interest Expense | ||||||||
| Other Expense | (28.00) | 57.00 | (11.00) | (28.00) | (24.00) | (34.00) | (136.00) | (17.00) |
| Pretax Income | (9,589) | (10,937) | (8,692) | (8,423) | (6,718) | (6,347) | (7,230) | (6,049) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (9,589) | (10,937) | (8,692) | (8,423) | (6,718) | (6,347) | (7,230) | (6,049) |
| Earnings Per Share (Basic) | (1.11) | (1.27) | (0.07) | (0.07) | (0.78) | (0.76) | (0.06) | (0.05) |
| Earnings Per Share (Diluted) | (1.11) | (1.27) | (0.07) | (0.07) | (0.78) | (0.76) | (0.06) | (0.05) |
| Weighted Average Shares Outstanding (Basic) | 8,622 | 8,611 | 129,171 | 129,170 | 8,622 | 8,391 | 125,773 | 125,732 |
| Weighted Average Shares Outstanding (Diluted) | 8,622 | 8,611 | 129,171 | 129,170 | 8,622 | 8,391 | 125,773 | 125,732 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ATOS
Atossa Therapeutics, Inc. (NASDAQ: ATOS) is a stock listed on the Nasdaq Stock Market under the ticker symbol ATOS. It last traded at $2.30 (Nov 2, 2026, 4:00 PM ET), up 6.0% on the day. That gives Atossa Therapeutics a market capitalisation of $21.7M.
Over the past 52 weeks ATOS has traded between $1.70 and $14.85.
For the quarter ended Mar 31, 2026 it reported a net loss of $9.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$9.6M |
| Dec 31, 2025 | — | -$10.9M |
| Sep 30, 2025 | — | -$8.7M |
| Jun 30, 2025 | — | -$8.4M |
From Atossa Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…